- ￥1999
- null
- TA423896
- 2025年07月06日
- Rabbit
- null
企业认证
相关产品推荐更多 >
![Caspase 1 (CASP1) Rabbit Monoclonal Antibody [Clone ID: OTIR2E3]](https://img1.dxycdn.com/p/s14/2025/0217/601/8427578297774731981.png!wh200)
Caspase 1 (CASP1) Rabbit Monoclonal Antibody [Clone ID: OTIR2E3]
￥1900
Anti-MVP Rabbit Polyclonal Antibody
￥1999Patched1 (Patched) mouse monoclonal antibody, clone OTI5C7 (formerly 5C7)
￥1999Histone H2A.X (H2AFX) Rabbit Monoclonal Antibody [Clone ID: OTIR1B2]
￥800PRMT7 Rabbit Monoclonal Antibody [Clone ID: R06-4F6]
￥1999
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at +4°C short term. Store at -22°C long term. Avoid freeze / thaw cycle.
- 克隆性：
Monoclonal
- 适应物种：
null
- 宿主：
Rabbit
- 规格：
100 ul
description：MC4 Receptor Antibody
symbol：MC4R
synonyms：MC4R; Melanocortin 4 receptor
locusid：4160
Concentration：lot specific
sub_category：Primary Antibodies
uniprot_id：P32245
Applications：WB
CNdelivery：2周
RecommendDilution：WB 1:500~1:2000
Reactivity：Human, Mouse, Rat
Immunogen：A synthesized peptide derived from human MC4 Receptor
Purification：Affinity-chromatography
Conjugation：Unconjugated
ProteinFamilies：null
ProteinPathways：null
GeneName：melanocortin 4 receptor
Background：Receptor specific to the heptapeptide core common to adrenocorticotropic hormone and alpha-, beta-, and gamma-MSH. This receptor is mediated by G proteins that stimulate adenylate cyclase.
Buffer：Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
isotypes_filter：IgG
predicted_size：37kDa
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Generation and Selection of Rabbit Antibody Libraries by Phage Display
The rabbit antibody repertoire is an exceptional source for both polyclonal antibodies (pAbs) and monoclonal antibodies (mAbs) that combine high specificity with high avidity and affinity, respectively. In contrast to rabbit pAbs
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
Conventionally, monoclonal antibodies (MAbs) are generated by fusing B cells from an immunized animal with myeloma cells from the same species (1 ). Several murine MAb have already been employed for in vivo diagnosis and therapy, including
技术资料暂无技术资料 索取技术资料
